FeesSafety
Pluang+
Home/Explore/US Market Price/Stocks/ABBV
icon
Up to 4x
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

AbbVie Inc (ABBV) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

AbbVie (ABBV) trades at $294.87, up 1.34% with strong technical momentum and bullish moving averages. The company demonstrates robust fundamentals with consistent earnings beats, including Q3 2026 EPS of $3.82 beating expectations of $3.73. Revenue growth accelerated to $61.16B in 2025, while Skyrizi and Rinvoq continue to drive growth offsetting Humira declines. Recent positive Phase 2 ovarian cancer data and institutional accumulation signal confidence in AbbVie's pipeline and execution.
AbbVie presents a compelling investment case with strong analyst support (70% buy ratings) and a $294 consensus price target near current levels. Key opportunities include sustained immunology growth and pipeline advancements, while risks center on patent cliffs in the 2030s and competitive pressures. The stock's elevated P/E ratio of 82.14 requires continued execution to justify valuation.
Read full analysis

Key Stats

  • Market Cap
    $521.11B
  • Volume
    6,896,546
  • Sector
    Health
  • 52W High
    $294.87
  • 52W Low
    $197.38
  • Typical Hold Time
    93 Days
  • Enterprise Value
    $585.36B
  • Div Yield
    2.35%
  • Trading Activity
    -
$293.55
52W Low: $197.38
27 Apr 2026
52W High: $294.87
30 Oct 2026

Track AbbVie Inc (ABBV) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, AbbVie Inc has traded between a low of $197.38 and a high of $294.87, highlighting its annual price range. Buy and sell AbbVie Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About AbbVie Inc

AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

Most Recent News

Content is generated by Aura AI

Alvotech to present at four major investor conferences in November across Europe.

Alvotech, a global biotechnology company specializing in biosimilar medicines, will participate in four international investor conferences in November held in the UK, Norway, and Sweden. These events include presentations and analyst discussions host...

Market News
17 minutes ago
Na
Neutral
Alvotech to present at four major investor conferences in November across Europe.

Deadlines set for lead plaintiff in class actions against Tigo Energy, Fluence Energy, and Anavex Life Sciences

Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Tigo Energy, Fluence Energy, and Anavex Life Sciences. The lawsuits allege these companies made false or misleading stat...

Market News
17 minutes ago
Holzer & Holzer, Llc
Bearish
news icon
Deadlines set for lead plaintiff in class actions against Tigo Energy, Fluence Energy, and Anavex Life Sciences

Alvotech to present at multiple investor conferences in November 2026

Alvotech, a global biotech company specializing in biosimilar medicines, announced its management team will participate in several investor conferences throughout November 2026. These include events in London, Oslo, and Stockholm, featuring presentat...

Market News
17 minutes ago
Na
Neutral
Alvotech to present at multiple investor conferences in November 2026
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $521.11B
  • Volume
    6,896,546
  • Sector
    Health
  • 52W High
    $294.87
  • 52W Low
    $197.38
  • Typical Hold Time
    93 Days
  • Enterprise Value
    $585.36B
  • Div Yield
    2.35%
  • Trading Activity
    -
$293.55
52W Low: $197.38
27 Apr 2026
52W High: $294.87
30 Oct 2026

Track AbbVie Inc (ABBV) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, AbbVie Inc has traded between a low of $197.38 and a high of $294.87, highlighting its annual price range. Buy and sell AbbVie Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!